GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,258,000 | -2.6% | 94,062 | -17.7% | 0.00% | 0.0% |
Q4 2021 | $3,346,000 | +35.5% | 114,309 | +17.9% | 0.00% | +100.0% |
Q3 2021 | $2,469,000 | -3.3% | 96,918 | +32.9% | 0.00% | 0.0% |
Q2 2021 | $2,553,000 | +44.0% | 72,901 | +67.6% | 0.00% | 0.0% |
Q1 2021 | $1,773,000 | -6.6% | 43,499 | -0.7% | 0.00% | 0.0% |
Q4 2020 | $1,898,000 | -25.6% | 43,823 | -5.3% | 0.00% | -50.0% |
Q3 2020 | $2,552,000 | -39.3% | 46,288 | -30.5% | 0.00% | -33.3% |
Q2 2020 | $4,205,000 | +73.4% | 66,608 | +40.3% | 0.00% | +50.0% |
Q1 2020 | $2,425,000 | -46.7% | 47,475 | -17.1% | 0.00% | -33.3% |
Q4 2019 | $4,550,000 | +129.0% | 57,239 | +39.8% | 0.00% | +50.0% |
Q3 2019 | $1,987,000 | -15.8% | 40,945 | -8.7% | 0.00% | 0.0% |
Q2 2019 | $2,360,000 | +331.4% | 44,866 | +334.5% | 0.00% | – |
Q1 2019 | $547,000 | +108.8% | 10,325 | +62.0% | 0.00% | – |
Q4 2018 | $262,000 | +30.3% | 6,374 | +20.3% | 0.00% | – |
Q3 2018 | $201,000 | -32.6% | 5,297 | -19.6% | 0.00% | – |
Q2 2018 | $298,000 | -78.1% | 6,592 | -76.6% | 0.00% | -100.0% |
Q1 2018 | $1,358,000 | +15.6% | 28,113 | -5.9% | 0.00% | 0.0% |
Q4 2017 | $1,175,000 | +5.3% | 29,868 | -16.9% | 0.00% | 0.0% |
Q3 2017 | $1,116,000 | +31.9% | 35,927 | +16.1% | 0.00% | 0.0% |
Q2 2017 | $846,000 | -25.1% | 30,943 | +0.9% | 0.00% | -50.0% |
Q1 2017 | $1,130,000 | – | 30,659 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |